Bicycle Therapeutics Plc

Ownership Transactions Reported by 20 Insiders

Symbol
BCYC on Nasdaq
Industry
Pharmaceutical Preparations
Location
Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, United Kingdom

Insiders trading volume in the past year

Bicycle Therapeutics Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director, 10%+ Owner $382M Jun 17, 2024
Kate Bingham Director $32.7M Jul 13, 2021
Kevin Lee CHIEF EXECUTIVE OFFICER, Director $7.54M -$320K -4.06% Jul 3, 2024
Gregory Paul Winter Director $3.16M Jan 2, 2024
Michael Skynner Chief Technology Officer $1.84M -$96.8K -4.99% Jul 3, 2024
Alistair Milnes Chief Operating Officer $1.4M -$96.8K -6.47% Jul 3, 2024
Nicholas Keen Chief Scientific Officer $1.36M -$85.7K -5.95% Jul 3, 2024
Nigel Crockett Chief Business Officer $919K -$96.8K -9.53% Jul 3, 2024
Santiago Arroyo Chief Development Officer $683K Feb 6, 2024
Dominic Smethurst Chief Medical Officer $642K Jan 3, 2023
Pierre Legault Director $586K Jan 2, 2024
Lee Kalowski President and CFO $530K Apr 3, 2023
Travis Alvin Thompson Chief Accounting Officer $453K -$18.2K -3.86% Jul 3, 2024
Michael Charles Ferguson Hannay Chief Prod & Supply Chain Off $445K -$10.6K -2.33% Jul 3, 2024
Veronica GH Jordan Director $293K Jan 2, 2024
Richard N. Kender Director $293K Jan 2, 2024
Janice Bourque Director $293K Jan 2, 2024
Jose-Carlos Gutierrez-Ramos Director $293K Jan 2, 2024
Stephen H. Sands Director $210K Feb 20, 2024
Alethia Young Chief Financial Officer $210K Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for Bicycle Therapeutics Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.